다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Primary care : Clinics in Office Practice, v.27 no.3, 2000년, pp.541 - 587
Yu, Jack N. , Cunningham, Janet A. , Thouin, Sheryl Rosenberg , Gurvich, Tatyana , Liu, Davis
AI-Helper
Coronary heart disease (CHD) is prevalent and often related to an unhealthy diet and hyperlipidemia. The diagnosis of hyperlipidemia should be carefully made, using more than one measurement in the manner described. An assessment of risks allows one to decide whom to treat. Patients with CHD should ...
1998 AAFP Reference Manual
Am J Clin Nutr Abbey 57 391 1993 10.1093/ajcn/57.3.391 Oxidation of low-density lipoproteins: Intraindividual variability and the effect of dietary linoleate supplementation
The Medical Letter Abramowicz 40 13 1998 Cerivastatin for hypercholesterolemia
The Medical Letter Abramowicz 40 117 1998 Choice of lipid-lowering drugs
Med Res Rev Agarwal 16 111 1996 10.1002/(SICI)1098-1128(199601)16:1<111::AID-MED4>3.0.CO;2-5 Therapeutic actions of garlic constituents
N Engl J Med Alpha-Tocopherol, Beta-carotene Cancer Prevention Study Group 15 1029 1984 The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers
JAMA Alvins 279 445 1998 10.1001/jama.279.6.445 Improving the prediction of coronary heart disease to aid in the management of high cholesterol levels
Ann Intern Med Alvins 125 502 1996 10.7326/0003-4819-125-6-199609150-00012 Lowering risk without lowering cholesterol: Implications for national cholesterol policy
Ann Intern Med American College of Physicians 124 515 1996 10.7326/0003-4819-124-5-199603010-00012 Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults
American Diabetes Association and American Dietetic Association. Exchange Lists for Meal Planning, Chicago, 1995.
Circulation American Heart Association 99 2480 1999 Consensus statement on heart disease in women
Am Heart J Ames 106 1207 1983 10.1016/0002-8703(83)90176-X Metabolic disturbances increasing the risk of coronary heart disease during diuretic-based antihypertensive therapy: Lipid alteration and glucose intolerance
Top Clin Nutr Anderson 3 21 1988 10.1097/00008486-198804000-00005 Dietary fiber and heart disease: Current management concepts and recommendations
N Engl J Med Anderson 333 276 1995 10.1056/NEJM199508033330502 Meta-analysis of the effects of soy protein intake on serum lipids
Circulation Anderson 83 356 1991 10.1161/01.CIR.83.1.356 An updated coronary risk profile
JAMA Andersen 281 335 1999 10.1001/jama.281.4.335 Effects of lifestyle activity vs structured aerobic exercise in obese women: A randomized trial
N Engl J Med Andrade 332 1125 1995 10.1056/NEJM199504273321703 Discontinuation of antihyperlipidemic drugs-do rates reported in clinical trials reflect raters in primary care settings?
JAMA Avorn 279 1458 1998 10.1001/jama.279.18.1458 Persistence of use of lipid-lowering medications: A cross-national study
Arch Intern Med Bagdade 125 129 1970 10.1001/archinte.1970.00310010131015 Steroid-induced hyperlipidemia. A complication of high-dose corticosteroid therapy
Bayer Corp. Baycol product information, 1997.
Heart Disease and Stroke Bays 1 357 1992 Drug treatment of dyslipidemias: Practical guidelines for the primary care physician
Nutrition Today Berdanier 29 28 1994 10.1097/00017285-199407000-00009 Omega-3 fatty acids: Panacea?
N Engl J Med Bershad 313 981 1985 10.1056/NEJM198510173131604 Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne
Bristol-Meyers Squibb Co. Pravachol product information, 1996.
Heart Disease and Stroke Brown 1 405 1992 Genetic lipoprotein abnormalities producing high blood cholesterol
Cardiology Brugada 87 194 1996 10.1159/000177086 Changes in plasma cholesterol levels after hospitalization for acute coronary events
N Engl J Med Buchwald 323 946 1990 10.1056/NEJM199010043231404 Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of Hyperlipidemias (POSCH)
J Am Coll Card Califf 27 1007 1996 10.1016/0735-1097(96)87733-3 Task for 5: Stratification of patients into high medium and low risk subgroups for purposes of risk factor management
J Am Diet Assoc Camelon 98 1155 1998 10.1016/S0002-8223(98)00267-3 The plate model: A visual method of teaching meal planning
N Engl J Med Campeau 336 153 1997 10.1056/NEJM199701163360301 The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low dose anticoagulation on obstructive changes in saphenous vein coronary artery bypass grafts
Can Med Assoc J Canadian Task Force on the Periodic Health Examination 148 521 1993 Periodic health examination 1993 update: 2. Lowering the blood total cholesterol level to prevent coronary heart disease
JAMA Castelli 256 2835 1986 10.1001/jama.1986.03380200073024 Incidence of coronary heart disease and lipoprotein levels. The Framingham Study
Cholesterol Lowering in the Patient with Coronary Heart Disease 15 1997 NIH Publication 97-3794
1998 Clinician's Handbook of Preventive Services
Conner PE. Evaluation of publicly available scientific evidence regarding certain nutrient-disease relationships: Omega-3 fatty acids and heart disease. LSRO Report, 1991.
JAMA Cooper 267 1652 1992 10.1001/jama.1992.03480120090039 Blood lipid measurements. Variations and practical utility
JAMA Dalen 275 67 1996 10.1001/jama.1996.03530250071030 Does lowering cholesterol cause cancer?
Am J Med Day 76 94 1984 10.1016/0002-9343(84)90963-X Adrenergic mechanisms in the control of plasma lipids in man
Circulation De Lorgeril 99 779 1999 10.1161/01.CIR.99.6.779 Mediterranean diet: Traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the lyon diet heart study
Am J Clin Nutr Denke 54 1036 1991 10.1093/ajcn/54.6.1036 Effects of fats high in stearic acid on lipid and lipoprotein concentrations in med
Arch Intern Med Denke 155 17 1995 10.1001/archinte.1995.00430010021004 Cholesterol-lowering diets: A review of the evidence
JAMA. Downs 279 1615 1998 10.1001/jama.279.20.1615 Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS, Air Force/Texas Coronary Atherosclerosis Prevention Study
171f 1999 Drug Facts and Comparisons
Clin Pharmacol Ther Dujovne 36 157 1984 10.1038/clpt.1984.156 Serum lipids in normo- and hyperlipidemics after methyldopa and propranolol
Dunham D, Patel TC, Statin comparison. Prescriber's Letter 1999 (supplement)
J Am Board Fam Pract Eaton 9 312 1996 Family history and premature coronary heart disease
JAMA Expert Panel 269 3015 1993 10.1001/jama.1993.03500230097036 Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II)
Clinical Geriatrics Fellicitta 3 56 1995 Lipids in the elderly
JAMA Fisher 281 446 1999 10.1001/jama.281.5.446 Avoiding the unintended consequences of growth in medical care-how might more be worse?
J Am Diet Assoc Food and Nutrition Science Alliance 94 1098 1994 Statement on trans fatty acids [editor's comment]
N Engl J Med Fredrickson 276 34 1967 10.1056/NEJM196701052760107 Fat transport in lipoproteins-an integrated approach to mechanisms and disorders
Circulation Freedman 81 1498 1990 10.1161/01.CIR.81.5.1498 Body fat distribution and male/female differences in lipids and lipoproteins
N Engl J Med Frick 317 1237 1987 10.1056/NEJM198711123172001 Helsinki Heart Study Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: Safety of treatment, changes in risk factors, and incidence or coronary heart disease
Am J Med Frishman 75 54 1983 10.1016/0002-9343(83)90137-7 Multiclinic comparison of labetalol to metoprolol in treatment of mild-to-moderate systemic hypertension
Circulation Frolkis 98 851 1998 10.1161/01.CIR.98.9.851 Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATP II) Guidelines
Circulation Furberg 90 1679 1994 10.1161/01.CIR.90.4.1679 Effect of lovastatin on early carotid atherosclerosis and cardiovascular events
Ann Intern Med Garber 124 518 1996 10.7326/0003-4819-124-5-199603010-00013 Cholesterol screening in asymptomatic adults, revisited
N Engl J Med Gaziano 320 1829 1993 10.1056/NEJM199312163292501 Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction
Am J Cardiol Gaziano 83 52 1999 10.1016/S0002-9149(98)00782-6 Type of alcoholic beverage and risk of myocardial infarction
J Am Diet Assoc Glore 94 425 1994 10.1016/0002-8223(94)90099-X Soluble fiber and serum lipids: A literature review
Ann Intern Med Grimm 94 7 1981 10.7326/0003-4819-94-1-7 Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients
JAMA Grover 274 801 1995 10.1001/jama.1995.03530100041032 Identifying adults at increased risk of coronary disease
Arch Intern Med Grover 159 592 1999 10.1001/archinte.159.6.593 Cost-effectiveness of 3-Hydroxy-3methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease
Circulation Grundy 97 1876 1998 10.1161/01.CIR.97.18.1876 Primary prevention of coronary heart disease guidance from Framingham
Circulation Grundy 95 1683 1997 10.1161/01.CIR.95.6.1683 When to start cholesterol-lowering therapy in patients with coronary heart disease
Arteriosclerosis Grundy 8 95 1988 10.1161/01.ATV.8.1.95 Workshop on the impact of dietary cholesterol on plasma lipoproteins and atherogenesis
Am J Cardiol Grundy 81 18B 1998 10.1016/S0002-9149(98)00033-2 Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome
Guide to Clinical Preventive Services 1996 Report of the U.S. Preventive Services Task Force
Gurr J, Chang M. All natural Cholestin, a new cholesterol-lowering dietary supplement. Pharmanex, Inc, 1997.
Clinical Geriatrics Guthrie 6 no 13 35 1998 Treating cholesterol in the elderly
Am J Clin Nutr Halliwell 61 suppl 670S 1995 10.1093/ajcn/61.3.670S Oxidation of low-density lipoproteins: Questions of initiation, propagation, and the effect of antioxidants
J Am Coll Cardiol Hambrecht 22 468 1993 10.1016/0735-1097(93)90051-2 Various intensities of leisure time physical activity in patients with coronary artery disease: Effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions
JAMA Hamilton 273 1032 1995 10.1001/jama.1995.03520370074040 The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease: Estimating the benefits of increasing HDL-C
Lancet Hansson 351 1755 1998 10.1016/S0140-6736(98)04311-6 Effects of intensive blood-pressure lowering and low-dose aspirin in patients with HTN principal results of the Hypertension Optimal Treatment (HOT) randomised trial
Am Fam Physician Havranek 59 1455 1999 Primary Prevention of CHD: Nine ways to reduce risk
JAMA Hebert 278 313 1997 10.1001/jama.1997.03550040069040 Cholesterol lowering with statin drugs, risk of stroke and total mortality
Ann Intern Med Hodis 124 548 1996 10.7326/0003-4819-124-6-199603150-00002 Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: A randomized, controlled clinical trial
BMJ Hu 317 1341 1998 10.1136/bmj.317.7169.1341 Frequent nut consumption and risk of coronary heart disease in women: Prospective cohort study
Am Fam Physician Huffman 53 1 333 1996 Significance of cholesterol levels in elderly persons
JAMA. Hulley 280 605 1998 10.1001/jama.280.7.605 Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
JAMA Hulley 269 1416 1993 10.1001/jama.1993.03500110084041 Should we be measuring blood cholesterol levels in young Adults?
Medical Decision Making Hux 15 152 1995 10.1177/0272989X9501500208 Communicating the benefits of chronic preventive therapy: Does the format of efficacy data determine patients' acceptance of treatment?
Hyperlipidemia 1994 Internal Medicine
Jancin 1995 Screening for familial hypercholesterolemia
Am J Cardiol Kannel 76 69C 1995 10.1016/S0002-9149(99)80474-3 Range of serum cholesterol values in the population developing coronary artery disease
N Engl J Med Katan 332 1024 1995 10.1056/NEJM199504133321509 Fish and heart disease
J Am Coll Card Kearney 33 1305 1999 The anti-thrombotic effects of statins
Atherosclerosis Keller 86 1 1991 10.1016/0021-9150(91)90093-I LDL-apheresis: Results of long term treatment and vascular outcome
Circulation 41 suppl I 1 1970 Coronary heart disease in seven countries
Ann Intern Med Kinosian 121 641 1994 10.7326/0003-4819-121-9-199411010-00002 Cholesterol and coronary heart disease: Predicting risks by levels and ratios
Am J Cardiol Klatsky 71 467 1993 10.1016/0002-9149(93)90460-T Alcoholic beverage choice and risk of coronary artery disease mortality: Do red wine drinkers fare best?
Am Fam Physician Kountz 58 1541 1998 Cardiovascular risk profiling in blacks: Don't forget the lipids
J Am Diet Assoc Kris-Etherton 88 1373 1988 10.1016/S0002-8223(21)08023-8 The effect of diet on plasma lipids, lipoproteins, and coronary heart disease
Am J Clin Nutr Kris-Etherton 69 581 1999 10.1093/ajcn/69.4.581 Effects of the national cholesterol education program's step I and step II dietary intervention programs on cardiovascular disease risk factors: A meta-analysis
JAMA. Krumholz 272 1335 1994 10.1001/jama.1994.03520170045034 Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years
Krummel 52 1996 Krause's Food, Nutrition & Diet Therapy Lipids
Clin Invest Med Kurowska 20 162 1997 Effects of substituting dietary soybean protein and soybean oil for milk protein and milk fat in hypercholesterolemic subjects
Ann Intern Med LaRosa 124 505 1996 10.7326/0003-4819-124-5-199603010-00008 Cholesterol agnostics
Am J Med Lasser 76 52 1984 10.1016/0002-9343(84)90957-4 Effects of anti hypertensive therapy on plasma lipids and lipo proteins in the multiple risk factor intervention trial
Prev Med Lavedrine 28 333 1999 10.1006/pmed.1999.0460 Blood cholesterol and walnut consumption: A cross-sectional survey in France
Circulation Leaf 99 733 1999 10.1161/01.CIR.99.6.733 Dietary prevention of coronary heart disease: The Lyon diet heart study [editorial]
Br J Clin Pharmacol Leren 13 441S 1982 10.1111/j.1365-2125.1982.tb01954.x Antihypertensive drugs and blood lipids: The Oslo study
Ann Intern Med Lewis 129 681 1998 10.7326/0003-4819-129-9-199811010-00002 Effect of pravastatin on cardiovascular events in older patients with myocardial infarctions and cholesterol levels in the average range: Results of the cholesterol and recurrent events (CARE) Trial
J Am Coll Cardiol. Liao 30 1200 1997 10.1016/S0735-1097(97)00278-7 Mortality from coronary heart disease and cardiovascular disease among U.S. Hispanics: Findings from the National Health Interview Study
Libby 1350 1998 Harrison's Principles of Internal Medicine. Vascular Disease: Atherosclerosis
Circulation Lichtenstein AH for the American Heart Association 95 2588 1997 10.1161/01.CIR.95.11.2588 Trans fatty acids, plasma lipid levels, and risk of developing cardiovascular disease
JAMA Lipid Research Clinics 251 351 1984 10.1001/jama.1984.03340270029025 Coronary primary prevention trial results. I. Reduction in incidence of coronary heart disease
JAMA Lipid Research Clinics 251 365 1984 10.1001/jama.1984.03340270043026 Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary disease cholesterol lowering
N Engl J Med 339 1347 1998 Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
Am J Cardiol Lowenstein 53 21A 1984 10.1016/0002-9149(84)90830-0 Effects of prazosin on serum lipids in patients with essential hypertension
JAMA LRC 251 351 1984 10.1001/jama.1984.03340270029025 Lipid Research Clinic Program: The Lipid Research Clinics Coronary Primary Prevention Trial results. I and II
J Am Board Fam Pract McBride 9 382 1996 Is heart disease all in the family? Family history and cardiovascular disease
Can Med Assoc J McCormack 157 422 1997 Primary prevention of heart disease and stroke: A simplified approach to estimating risk of events and making drug treatment decisions
McDowell 1994 Energy and macronutrient intakes of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-1991. Advance data from vital and health statistics; No 225
BMJ Medical Research Council's General Practice Research Framework 312 473 1996 10.1136/bmj.312.7029.473 Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy
Meese S. Physicians lax in treating high cholesterol (Froelich JB presenting at Am Coll Cardiol). Medical Tribune, April 8, 1999, p 7.
Merck & Co. Zocor product information, 1998.
Merck seeking to market OTC cholesterol drug, American Medical News 42:49, May 3, 1999.
Clinical Geriatrics Miller 3 56 1995 Lipids, lipoproteins, and cardiovascular disease in older women
National Cholesterol Education Program 1991 Report of the expert panel on blood cholesterol levels in children and adolescents. NIH publication 91-2732
National Cholesterol Education Program 1993 Second Report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment panel II). NIH publication 93-3095
National Cholesterol Education Program Working Group on Lipoprotein Measurement 1995 Recommendations on Lipoprotein Measurement. NIH publication 95-3044
JAMA Newman 275 55 1996 10.1001/jama.1996.03530250059028 Carcinogenicity of lipid-lowering drugs
JAMA 269 505 1993 10.1001/jama.269.4.505 NIH consensus development panel on triglyceride, high-density lipoprotein, and coronary heart disease. Triglyceride, high-density lipoprotein, and coronary heart disease
Am J Clin Nutr Nordoy 57 634 1993 10.1093/ajcn/57.5.634 Individual effects of dietary saturated fatty acids and fish oil on plasma lipids and lipoproteins in normal men
Am J Clin Nutr Nydahl 59 115 1994 10.1093/ajcn/59.1.115 Lipid-lowering diets enriched with monounsaturated or polyunsaturated fatty acids but low in saturated fatty acids have similar effects on serum lipid concentrations in hyperlipidemic patients
Am J Cardiol Ornisch 82 72T 1998 10.1016/S0002-9149(98)00744-9 Avoiding revascularization with lifestyle changes: The multicenter lifestyle demonstration project
Pharmacol Res Commun Pagnan 11 227 1979 10.1016/S0031-6989(79)80084-3 Effects of labetalol on lipid and carbohydrate metabolisms
South Med J Paterson 87 236 1994 10.1097/00007611-199402000-00018 Impact on intensive lipid modulation on angiographically defined coronary disease
South Med J Patterson 76 239 1983 10.1097/00007611-198302000-00023 Niacin hepatitis
F-D-C Reports Pharmanex 24 1 1997 Cholestin dietary supplement cholesterol-reduction data
Consultant Prisant 1123 1996 Hypercholesterolemia Q&A: Rational use of cholesterol-lowering diets and drugs
Raasch 73 1992 Applied Therapeutics: The Clinical Use of Drugs Hyperlipidemias
BMJ Ramsay 303 9553 1991 Dietary reduction of serum cholesterol concentration: Time to think again
Recommendations for Improving Cholesterol Measurement 1990 A Report from the Laboratory Standardization Panel of the National Cholesterol Education Program. NIH publication 90-2964
J Fam Pract Rembold 42 577 1996 Number-needed-to-treat analysis of the prevention of myocardial infarction and death by antidyslipidemic therapy
JAMA Rosenson 279 1643 1998 10.1001/jama.279.20.1643 Antiatherothrombotic properties of statins
N Engl J Med Rubins 341 410 1999 10.1056/NEJM199908053410604 Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
Circulation Sacks 997 1446 1998 10.1161/01.CIR.97.15.1446 Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the cholesterol and recurrent events trial
N Engl J Med Sacks 335 1001 1996 10.1056/NEJM199610033351401 The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
Sandoz Pharmaceutical Corp. Lescol product information, 1996.
Lancet Scandinavian Simvastatin Survival Study Group 344 1383 1994 Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
Am J Clin Nutr Schaefer 61 suppl 726S 1995 10.1093/ajcn/61.3.726S Lipoproteins, nutrition, aging, and atherosclerosis
J Gen Intern Med Schectman 11 277 1996 10.1007/BF02598268 Physician extenders for cost-effective management of hypercholesterolemia
Am J Cardiol Schrott 75 34 1995 10.1016/S0002-9149(99)80523-2 Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy
J Am Board Fam Pract Schwenk 7 242 1994 Hepatitis caused by low-dose sustained-release niacin
J Fam Pract Shaughnessy 40 498 1995 Simvastatin decreases mortality
JAMA SHEP Cooperative Research Groups 265 3255 1991 10.1001/jama.1991.03460240051027
N Engl J Med Shepherd 333 1301 1995 10.1056/NEJM199511163332001 Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
Nutrition Today Simopoulous 29 24 1994 10.1097/00017285-199407000-00008 The 1st Congress of the International Society for the Study of Fatty Acids and Lipids (ISSFAL): Fatty acids and lipids from cell biology to human disease
Ann NY Acad Sci Sirtori 676 188 1993 10.1111/j.1749-6632.1993.tb38734.x Soybean protein diet and plasma cholesterol: From therapy to molecular mechanisms
JAMA Stamler 256 2823 1986 10.1001/jama.1986.03380200061022 Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)
Statins
N Engl J Med Stefanick 339 L12 1998 10.1056/NEJM199807023390103 Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol
169 1987 Hypercholesterolemia and Atherosclerosis. Pathogenesis and Prevention.
Circulation Stone 94 2337 1996 10.1161/01.CIR.94.9.2337 Fish consumption, fish oil, lipids, and coronary heart disease
Am J Clin Nutr Sundram 59 841 1994 10.1093/ajcn/59.4.841 Dietary palmitic acid results in lower serum cholesterol than does a lauric-myristic acid combination in normolipemic humans
Circulation Task Force on Risk Reduction 93 1067 1996 10.1161/01.CIR.93.6.1067 AHA cholesterol screening in asymptomatic adults, no cause to change
Am J Clin Nutr Tholstrup 59 371 1994 10.1093/ajcn/59.2.371 Fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic acid or high in myristic and lauric acids
Circulation Tribble DL for the American Heart Association 99 591 1999 10.1161/01.CIR.99.4.591 Antioxidant consumption and risk of coronary heart disease: Emphasis on vitamin C, vitamin E, and beta-carotene
U 1996 . Preventive Services Task Force: Guide to Clinical Preventive Services
Valagussa F, chairman, Gruppo Italiano Per Lo Studio Della Sopravivenza Nell'Infarto (GSSI) Prevention Study: Presented at the annual meeting of the American College of Cardiology. New Orleans, LA, March 1999.
Circulation Van Horn 95 2701 1997 10.1161/01.CIR.95.12.2701 AHA Neducak/Scientific Statement. Fiber, lipids, and coronary heart disease: A statement for healthcare professionals from the nutrition committee, American Heart Association
Ann Intern Med Von Schacky 130 554 1999 10.7326/0003-4819-130-7-199904060-00003 The effect of dietary omega-3 fatty acids on coronary atherosclerosis: A randomized, double-blind, placebo-controlled trial
JAMA Walsh 274 1152 1995 10.1001/jama.1995.03530140064034 Treatment of hyperlipidemia in women
Ann Intern Med Warshafsky 119 599 1993 10.7326/0003-4819-119-7_Part_1-199310010-00009 Effect of garlic on total serum cholesterol. A meta-analysis
Am Fam Physician Washington 59 2211 1999 Interventions to reduce cardiovascular risk factors in children and adolescents
Br J Clin Pharmacol Weinberger 14 127S 1982 10.1111/j.1365-2125.1982.tb02069.x Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension
Lancet 2 600 1984 WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol. Final mortality follow-up
Br Heart J WHO Committee of Principal Investigators 40 1069 1978 10.1136/hrt.40.10.1069 A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate
Am J Med Wilder 99 374 1995 10.1016/S0002-9343(99)80184-3 The effect of fasting status on the determination of low-density and high-density lipoprotein cholesterol
Am J Pub Health Willet 84 722 1994 10.2105/AJPH.84.5.722 Trans fatty acids: Are the effects only marginal?
Lancet Willett 341 581 1993 10.1016/0140-6736(93)90350-P Intake of trans fatty acids and risk of coronary heart disease among women
N Engl J Med Williams 334 1298 1996 10.1056/NEJM199605163342004 High-density lipoprotein cholesterol and other risk factors for coronary heart disease in female runners
Circulation Wilson 97 1837 1998 10.1161/01.CIR.97.18.1837 Prediction of coronary heart disease using risk factor categories
Eur Heart J Wood 19 1434 1998 10.1053/euhj.1998.1243 Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention
N Engl J Med Wood 325 461 1991 10.1056/NEJM199108153250703 The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women
Am J Clin Nutr Zock 61 617 1995 10.1093/ajcn/61.3.617 Dietary trans fatty acids and lipoprotein cholesterol
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.